Chai Discovery
Engineering better molecules using artificial intelligence.Chai has built an AI model that its founders claim can transform the process of designing molecules that bind to proteins and influence their function. The company aims to enable the creation of de novo antibodies and, ultimately, drugs.
Work Type
Onsite
Stage
Series A
Industry
Biotech
Location
San Francisco, United States